Charles Schwab’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.83M | Buy |
430,522
+81,499
| +23% | +$347K | ﹤0.01% | 2692 |
|
|
2025
Q1 | $1.31M | Buy |
349,023
+16,073
| +5% | +$60.4K | ﹤0.01% | 2749 |
|
|
2024
Q4 | $1.94M | Buy |
332,950
+2,189
| +0.7% | +$12.8K | ﹤0.01% | 2688 |
|
|
2024
Q3 | $3.95M | Buy |
330,761
+207,565
| +168% | +$2.48M | ﹤0.01% | 2484 |
|
|
2024
Q2 | $1.33M | Buy |
123,196
+36,239
| +42% | +$392K | ﹤0.01% | 2834 |
|
|
2024
Q1 | $984K | Sell |
86,957
-2,253
| -3% | -$25.5K | ﹤0.01% | 2799 |
|
|
2023
Q4 | $1.25M | Buy |
89,210
+9,258
| +12% | +$130K | ﹤0.01% | 2763 |
|
|
2023
Q3 | $987K | Hold |
79,952
| – | – | ﹤0.01% | 2802 |
|
|
2023
Q2 | $722K | Buy |
79,952
+61,372
| +330% | +$554K | ﹤0.01% | 2885 |
|
|
2023
Q1 | $64.5K | Hold |
18,580
| – | – | ﹤0.01% | 3305 |
|
|
2022
Q4 | $45.5K | Hold |
18,580
| – | – | ﹤0.01% | 3377 |
|
|
2022
Q3 | $52K | Sell |
18,580
-118,686
| -86% | -$332K | ﹤0.01% | 3323 |
|
|
2022
Q2 | $559K | Sell |
137,266
-54,265
| -28% | -$221K | ﹤0.01% | 3033 |
|
|
2022
Q1 | $816K | Sell |
191,531
-11,079
| -5% | -$47.2K | ﹤0.01% | 2931 |
|
|
2021
Q4 | $1.9M | Buy |
202,610
+6,586
| +3% | +$61.7K | ﹤0.01% | 2717 |
|
|
2021
Q3 | $5.4M | Buy |
196,024
+114,590
| +141% | +$3.16M | ﹤0.01% | 2335 |
|
|
2021
Q2 | $2.28M | Buy |
81,434
+2,818
| +4% | +$78.9K | ﹤0.01% | 2672 |
|
|
2021
Q1 | $2.61M | Buy |
+78,616
| New | +$2.61M | ﹤0.01% | 2586 |
|